Sign in
BIOC Stock Price, Chart, Stats & News
Biocept, Inc.
Save
Biocept, Inc. (BIOC) does not currently pay a dividend.
450,786
Market cap
–
Current P/E
–
Forward P/E
BIOC chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | -9.99% |
Operating margin | -123.69% |
Pretax margin | -124.57% |
Net margin | -124.09% |
Effective tax rate | 0.39% |
ROA | -103.93% |
ROE | -138.49% |
D/E | 1.37x |
Interest coverage ratio | -101.21x |
BIOC valuation
P/E | – |
P/S | 0.02x |
P/B | 0.03x |
P/CF | -0.02x |
P/FCF | -0.03x |
P/OCF | -0.02x |
PEG | -0.00x |
EV multiple | -0.04x |
About
Biocept, Inc. is a company specializing in molecular diagnostics for cancer, primarily focused on developing and commercializing advanced diagnostic assays based on proprietary technology. These tests analyze circulating tumor cells (CTCs) and cell-free tumor DNA and RNA (ctDNA/ctRNA), primarily using standard blood samples. These assays furnish crucial insights to healthcare professionals, enabling them to identify specific genetic changes (oncogenic alterations) that qualify certain cancer patients for targeted therapies.
Similar securities
Based on sector and market capitalization
Report issue